GRADE 3A FOLLICULAR LYMPHOMA
Clinical trials for GRADE 3A FOLLICULAR LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new GRADE 3A FOLLICULAR LYMPHOMA trials appear
Sign up with your email to follow new studies for GRADE 3A FOLLICULAR LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New Low-Dose drug shows promise for untreated lymphoma patients
Disease control Recruiting nowThis study tests whether a low dose of the drug mosunetuzumab is safe and works well for people with slow-growing B-cell lymphoma who have not had treatment before. About 20 adults with follicular or marginal zone lymphoma will receive the drug to see if it shrinks tumors. The go…
Matched conditions: GRADE 3A FOLLICULAR LYMPHOMA
Phase: PHASE2 • Sponsor: University of Washington • Aim: Disease control
Last updated May 01, 2026 15:57 UTC
-
New drug combo shows promise for slowing lymphoma growth
Disease control Recruiting nowThis study tests two drugs, acalabrutinib and obinutuzumab, in people with untreated follicular lymphoma or other slow-growing lymphomas. The goal is to see if the combination can shrink tumors and keep the cancer under control. About 49 adults will take part. The treatment is no…
Matched conditions: GRADE 3A FOLLICULAR LYMPHOMA
Phase: PHASE2 • Sponsor: Emory University • Aim: Disease control
Last updated Apr 30, 2026 15:48 UTC
-
New drug combo aims to outsmart tough lymphoma
Disease control Recruiting nowThis study tests whether combining two drugs, pirtobrutinib and mosunetuzumab, can better treat follicular lymphoma that has come back or not responded to prior therapy. About 22 adults with grade 1-3a lymphoma will receive the combination. The goal is to increase the chance of c…
Matched conditions: GRADE 3A FOLLICULAR LYMPHOMA
Phase: PHASE2 • Sponsor: University of Washington • Aim: Disease control
Last updated Apr 29, 2026 15:01 UTC